Structural Heart Devices Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2028

 

Structural Heart Devices Market

Clinical care advancements in cardiac interventions have been made possible by a wide variety of percutaneous therapy methods. The use of cutting-edge, catheter-based therapies for structural heart problems has increased during the last ten years. The effectiveness of many of these non-surgical, catheter-based interventional techniques has led to a rise in their acceptance among medical professionals and patients alike. Despite having a lesser volume than coronary treatments, structural cardiac interventions have become a distinct field of interventional cardiology.

With improvements in catheter-based therapy over the past ten years, the adoption of structural heart therapies has dramatically increased. Due to higher adoption of tried-and-true techniques, clinical expertise, and the prevalence of valvular heart diseases, heart valve therapies account for the majority of the Structural Heart Devices Market revenue in structural heart interventions.

An estimated 4 million Americans are thought to have mitral valve insufficiency, and there are 250,000 new cases of mitral regurgitation each year. The most common cause of VHD in affluent nations is degenerative valve disease, which has supplanted rheumatic heart disease. Rheumatic heart disease continues to be the leading cause of VHD in poor nations, accounting for 33.4 million cases worldwide each year.

The acceptance of such treatments has increased as a result of the availability of solid clinical evidence for transcatheter aortic valve replacement. To address the enormous unmet need for mitral valve treatment, numerous devices made for mitral valve repair and replacement operations are anticipated to hit the market. More complex structural heart treatments can now be performed using microinvasive techniques thanks to developments in interventional imaging, however building the requisite volume of structural heart procedures to stay knowledgeable and up to date is difficult in all geographic areas.

Heart Valve

·        Transcatheter Heart Valve

·        Mechanical Heart Valve

·        Surgical Heart Valve

Annuloplasty rings

Occlusion Devices

Top Companies involved are- Abbott Laboratories, Medtronic Plc., Edwards Lifesciences Corporation, Boston Scientific Corporation, CryoLife Inc., LivaNova Plc., Cook Group Incorporated, Endologix Inc., and W. L. Gore & Associates

Comments

Popular posts from this blog

Security Robot Market is Estimated To Witness High Growth Owing To Increasing Demand for Enhanced Surveillance

The Ever-Evolving Landscape of the Scottish Whisky Market during the Forecast Period 2019-2027

Monochloroacetic Acid (MCAA) Market Is Estimated To Witness High Growth Owing To Increasing Demand for Surfactants and Herbicides